-
1
-
-
33646269035
-
Pulmonary arterial hypertension in France: Results from a national registry
-
Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-1030
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 1023-1030
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
Bertocchi, M.4
Habib, G.5
Gressin, V.6
Yaici, A.7
Weitzenblum, E.8
Cordier, J.F.9
Chabot, F.10
Dromer, C.11
Pison, C.12
Reynaud-Gaubert, M.13
Haloun, A.14
Laurent, M.15
Hachulla, E.16
Simonneau, G.17
-
2
-
-
77954759389
-
Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (reveal
-
Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164-172
-
(2010)
Circulation
, vol.122
, pp. 164-172
-
-
Benza, R.L.1
Miller, D.P.2
Gomberg-Maitland, M.3
Frantz, R.P.4
Foreman, A.J.5
Coffey, C.S.6
Frost, A.7
Barst, R.J.8
Badesch, D.B.9
Elliott, C.G.10
Liou, T.G.11
McGoon, M.D.12
-
3
-
-
20544448927
-
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
-
Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111:3105-3111
-
(2005)
Circulation
, vol.111
, pp. 3105-3111
-
-
Sitbon, O.1
Humbert, M.2
Jaïs, X.3
Ioos, V.4
Hamid, A.M.5
Provencher, S.6
Garcia, G.7
Parent, F.8
Hervé, P.9
Simonneau, G.10
-
4
-
-
64849109410
-
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the american college of cardiology foundation task force on expert consensus documents and the american heart association developed in collaboration with the american college of chest physicians; American thoracic society, inc; And the pulmonary hypertension association
-
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573-1619
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1573-1619
-
-
McLaughlin, V.V.1
Archer, S.L.2
Badesch, D.B.3
Barst, R.J.4
Farber, H.W.5
Lindner, J.R.6
Mathier, M.A.7
McGoon, M.D.8
Park, M.H.9
Rosenson, R.S.10
Rubin, L.J.11
Tapson, V.F.12
Varga, J.13
-
5
-
-
0023238042
-
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy
-
Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation. 1987;76:135-141
-
(1987)
Circulation
, vol.76
, pp. 135-141
-
-
Rich, S.1
Brundage, B.H.2
-
6
-
-
68349091504
-
Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography
-
Hemnes AR, Forfia PR, Champion HC. Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl. 2009;169:4-19
-
(2009)
Int J Clin Pract Suppl
, vol.169
, pp. 4-19
-
-
Hemnes, A.R.1
Forfia, P.R.2
Champion, H.C.3
-
7
-
-
84881536905
-
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension
-
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. J Am Coll Cardiol Heart Fail. 2013;1:300-307
-
(2013)
J Am Coll Cardiol Heart Fail
, vol.1
, pp. 300-307
-
-
Brittain, E.L.1
Pugh, M.E.2
Wheeler, L.A.3
Robbins, I.M.4
Loyd, J.E.5
Newman, J.H.6
Austin, E.D.7
Hemnes, A.R.8
-
8
-
-
84922474984
-
Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function
-
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Larkin EK, Austin ED, Hemnes AR. Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Pulm Circ. 2013;3:589-598
-
(2013)
Pulm Circ
, vol.3
, pp. 589-598
-
-
Brittain, E.L.1
Pugh, M.E.2
Wheeler, L.A.3
Robbins, I.M.4
Loyd, J.E.5
Newman, J.H.6
Larkin, E.K.7
Austin, E.D.8
Hemnes, A.R.9
-
9
-
-
84988934897
-
Idiopathic and heritable pah perturb common molecular pathways, correlated with increased msx1 expression
-
Austin ED, Menon S, Hemnes AR, Robinson LR, Talati M, Fox KL, Cogan JD, Hamid R, Hedges LK, Robbins I, Lane K, Newman JH, Loyd JE, West J. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Pulm Circ. 2011;1:389-398
-
(2011)
Pulm Circ
, vol.1
, pp. 389-398
-
-
Austin, E.D.1
Menon, S.2
Hemnes, A.R.3
Robinson, L.R.4
Talati, M.5
Fox, K.L.6
Cogan, J.D.7
Hamid, R.8
Hedges, L.K.9
Robbins, I.10
Lane, K.11
Newman, J.H.12
Loyd, J.E.13
West, J.14
-
10
-
-
67649579669
-
Updated clinical classification of pulmonary hypertension
-
suppl
-
Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S43-S54
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.1
, pp. S43-S54
-
-
Simonneau, G.1
Robbins, I.M.2
Beghetti, M.3
Channick, R.N.4
Delcroix, M.5
Denton, C.P.6
Elliott, C.G.7
Gaine, S.P.8
Gladwin, M.T.9
Jing, Z.C.10
Krowka, M.J.11
Langleben, D.12
Nakanishi, N.13
Souza, R.14
-
11
-
-
67650786508
-
Association of the metabolic syndrome with pulmonary venous hypertension
-
Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW. Association of the metabolic syndrome with pulmonary venous hypertension. Chest. 2009;136:31-36
-
(2009)
Chest
, vol.136
, pp. 31-36
-
-
Robbins, I.M.1
Newman, J.H.2
Johnson, R.F.3
Hemnes, A.R.4
Fremont, R.D.5
Piana, R.N.6
Zhao, D.X.7
Byrne, D.W.8
-
12
-
-
71049130696
-
Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance
-
West J, Cogan J, Geraci M, Robinson L, Newman J, Phillips JA, Lane K, Meyrick B, Loyd J. Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics. 2008;1:45
-
(2008)
BMC Med Genomics
, vol.1
, pp. 45
-
-
West, J.1
Cogan, J.2
Geraci, M.3
Robinson, L.4
Newman, J.5
Phillips, J.A.6
Lane, K.7
Meyrick, B.8
Loyd, J.9
-
13
-
-
0001677717
-
Controlling the false discovery rate: A practical and powerful approach to multiple testing
-
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B. 1995;57:289-300
-
(1995)
J Royal Stat Soc B.
, vol.57
, pp. 289-300
-
-
Benjamini, Y.1
Hochberg, Y.2
-
14
-
-
33745125419
-
Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension
-
Elliott CG, Glissmeyer EW, Havlena GT, Carlquist J, McKinney JT, Rich S, McGoon MD, Scholand MB, Kim M, Jensen RL, Schmidt JW, Ward K. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation. 2006;113:2509-2515
-
(2006)
Circulation
, vol.113
, pp. 2509-2515
-
-
Elliott, C.G.1
Glissmeyer, E.W.2
Havlena, G.T.3
Carlquist, J.4
McKinney, J.T.5
Rich, S.6
McGoon, M.D.7
Scholand, M.B.8
Kim, M.9
Jensen, R.L.10
Schmidt, J.W.11
Ward, K.12
-
15
-
-
76749135710
-
Pulmonary arterial hypertension: Baseline characteristics from the reveal registry
-
Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376-387
-
(2010)
Chest
, vol.137
, pp. 376-387
-
-
Badesch, D.B.1
Raskob, G.E.2
Elliott, C.G.3
Krichman, A.M.4
Farber, H.W.5
Frost, A.E.6
Barst, R.J.7
Benza, R.L.8
Liou, T.G.9
Turner, M.10
Giles, S.11
Feldkircher, K.12
Miller, D.P.13
McGoon, M.D.14
-
16
-
-
84880704857
-
A novel channelopathy in pulmonary arterial hypertension
-
Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK. A novel channelopathy in pulmonary arterial hypertension. N Engl J Med. 2013;369:351-361
-
(2013)
N Engl J Med
, vol.369
, pp. 351-361
-
-
Ma, L.1
Roman-Campos, D.2
Austin, E.D.3
Eyries, M.4
Sampson, K.S.5
Soubrier, F.6
Germain, M.7
Trégouët, D.A.8
Borczuk, A.9
Rosenzweig, E.B.10
Girerd, B.11
Montani, D.12
Humbert, M.13
Loyd, J.E.14
Kass, R.S.15
Chung, W.K.16
-
17
-
-
77954758530
-
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era
-
Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156-163
-
(2010)
Circulation
, vol.122
, pp. 156-163
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
Bertocchi, M.4
Habib, G.5
Gressin, V.6
Yaïci, A.7
Weitzenblum, E.8
Cordier, J.F.9
Chabot, F.10
Dromer, C.11
Pison, C.12
Reynaud-Gaubert, M.13
Haloun, A.14
Laurent, M.15
Hachulla, E.16
Cottin, V.17
Degano, B.18
Jaïs, X.19
Montani, D.20
Souza, R.21
Simonneau, G.22
more..
-
18
-
-
0025837793
-
Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
-
D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343-349
-
(1991)
Ann Intern Med
, vol.115
, pp. 343-349
-
-
D'alonzo, G.E.1
Barst, R.J.2
Ayres, S.M.3
Bergofsky, E.H.4
Brundage, B.H.5
Detre, K.M.6
Fishman, A.P.7
Goldring, R.M.8
Groves, B.M.9
Kernis, J.T.10
-
19
-
-
84878491606
-
Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: The multicenter repherral study
-
Deaño RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, Gomberg-Maitland M. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med. 2013;173:887-893
-
(2013)
Jama Intern Med
, vol.173
, pp. 887-893
-
-
Deaño, R.C.1
Glassner-Kolmin, C.2
Rubenfire, M.3
Frost, A.4
Visovatti, S.5
McLaughlin, V.V.6
Gomberg-Maitland, M.7
-
20
-
-
73449118589
-
Pharmacogenomic discovery using cell-based models
-
Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, McLeod H, Dolan ME. Pharmacogenomic discovery using cell-based models. Pharmacol Rev. 2009;61:413-429
-
(2009)
Pharmacol Rev
, vol.61
, pp. 413-429
-
-
Welsh, M.1
Mangravite, L.2
Medina, M.W.3
Tantisira, K.4
Zhang, W.5
Huang, R.S.6
McLeod, H.7
Dolan, M.E.8
-
21
-
-
84863279449
-
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension
-
Johnson JA, Hemnes AR, Perrien DS, Schuster M, Robinson LJ, Gladson S, Loibner H, Bai S, Blackwell TR, Tada Y, Harral JW, Talati M, Lane KB, Fagan KA, West J. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2012;302:L474-L484
-
(2012)
Am J Physiol Lung Cell Mol Physiol
, vol.302
, pp. L474-L484
-
-
Johnson, J.A.1
Hemnes, A.R.2
Perrien, D.S.3
Schuster, M.4
Robinson, L.J.5
Gladson, S.6
Loibner, H.7
Bai, S.8
Blackwell, T.R.9
Tada, Y.10
Harral, J.W.11
Talati, M.12
Lane, K.B.13
Fagan, K.A.14
West, J.15
-
22
-
-
67649599147
-
Cellular and molecular basis of pulmonary arterial hypertension
-
suppl
-
Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S20-S31
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.1
, pp. S20-S31
-
-
Morrell, N.W.1
Adnot, S.2
Archer, S.L.3
Dupuis, J.4
Jones, P.L.5
MacLean, M.R.6
McMurtry, I.F.7
Stenmark, K.R.8
Thistlethwaite, P.A.9
Weissmann, N.10
Yuan, J.X.11
Weir, E.K.12
-
23
-
-
33745231792
-
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy
-
Awad MM, Dalal D, Cho E, Amat-Alarcon N, James C, Tichnell C, Tucker A, Russell SD, Bluemke DA, Dietz HC, Calkins H, Judge DP. DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet. 2006;79:136-142
-
(2006)
Am J Hum Genet
, vol.79
, pp. 136-142
-
-
Awad, M.M.1
Dalal, D.2
Cho, E.3
Amat-Alarcon, N.4
James, C.5
Tichnell, C.6
Tucker, A.7
Russell, S.D.8
Bluemke, D.A.9
Dietz, H.C.10
Calkins, H.11
Judge, D.P.12
-
24
-
-
33645527574
-
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy
-
Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A, Frigo G, Vettori A, Valente M, Towbin J, Thiene G, Danieli GA, Rampazzo A. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113:1171-1179
-
(2006)
Circulation
, vol.113
, pp. 1171-1179
-
-
Pilichou, K.1
Nava, A.2
Basso, C.3
Beffagna, G.4
Bauce, B.5
Lorenzon, A.6
Frigo, G.7
Vettori, A.8
Valente, M.9
Towbin, J.10
Thiene, G.11
Danieli, G.A.12
Rampazzo, A.13
-
26
-
-
42649092901
-
Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy
-
Awad MM, Calkins H, Judge DP. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008;5:258-267
-
(2008)
Nat Clin Pract Cardiovasc Med
, vol.5
, pp. 258-267
-
-
Awad, M.M.1
Calkins, H.2
Judge, D.P.3
-
27
-
-
33745848407
-
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
-
Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest. 2006;116:2012-2021
-
(2006)
J Clin Invest
, vol.116
, pp. 2012-2021
-
-
Garcia-Gras, E.1
Lombardi, R.2
Giocondo, M.J.3
Willerson, J.T.4
Schneider, M.D.5
Khoury, D.S.6
Marian, A.J.7
-
28
-
-
84890032027
-
Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling
-
Chow K, Fessel JP, Kaoriihida-Stansbury, Schmidt EP, Gaskill C, Alvarez D, Graham B, Harrison DG, Wagner DH Jr, Nozik-Grayck E, West JD, Klemm DJ, Majka SM. Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. Pulm Circ. 2013;3:31-49
-
(2013)
Pulm Circ
, vol.3
, pp. 31-49
-
-
Chow, K.1
Fessel, J.P.2
Kaoriihida-Stansbury Schmidt, E.P.3
Gaskill, C.4
Alvarez, D.5
Graham, B.6
Harrison, D.G.7
Wagner, D.H.8
Nozik-Grayck, E.9
West, J.D.10
Klemm, D.J.11
Majka, S.M.12
-
29
-
-
0141521654
-
Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin
-
Chunqiu Hou J, Pessin JE. Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin. Mol Biol Cell. 2003;14:3578-3591
-
(2003)
Mol Biol Cell
, vol.14
, pp. 3578-3591
-
-
Chunqiu Hou, J.1
Pessin, J.E.2
-
30
-
-
79960013903
-
Unrecognized glucose intolerance is common in pulmonary arterial hypertension
-
Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant. 2011;30:904-911
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 904-911
-
-
Pugh, M.E.1
Robbins, I.M.2
Rice, T.W.3
West, J.4
Newman, J.H.5
Hemnes, A.R.6
-
31
-
-
84875862818
-
A potential role for insulin resistance in experimental pulmonary hypertension
-
West J, Niswender KD, Johnson JA, Pugh ME, Gleaves L, Fessel JP, Hemnes AR. A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J. 2013;41:861-871
-
(2013)
Eur Respir J.
, vol.41
, pp. 861-871
-
-
West, J.1
Niswender, K.D.2
Johnson, J.A.3
Pugh, M.E.4
Gleaves, L.5
Fessel, J.P.6
Hemnes, A.R.7
-
32
-
-
43049092988
-
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension
-
Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest. 2008;118:1846-1857
-
(2008)
J Clin Invest
, vol.118
, pp. 1846-1857
-
-
Hansmann, G.1
De Jesus Perez, V.A.2
Alastalo, T.P.3
Alvira, C.M.4
Guignabert, C.5
Bekker, J.M.6
Schellong, S.7
Urashima, T.8
Wang, L.9
Morrell, N.W.10
Rabinovitch, M.11
-
33
-
-
39149106144
-
Mitochondrial metabolism, redox signaling, and fusion: A mitochondria-ros-hif-1alpha-kv1.5 o2-sensing pathway at the intersection of pulmonary hypertension and cancer
-
Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol. 2008;294:H570-H578
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.294
, pp. H570-H578
-
-
Archer, S.L.1
Gomberg-Maitland, M.2
Maitland, M.L.3
Rich, S.4
Garcia, J.G.5
Weir, E.K.6
-
34
-
-
33745155785
-
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: Similarities to human pulmonary arterial hypertension
-
Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thébaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, Weir EK, Archer SL. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation. 2006;113:2630-2641
-
(2006)
Circulation
, vol.113
, pp. 2630-2641
-
-
Bonnet, S.1
Michelakis, E.D.2
Porter, C.J.3
Andrade-Navarro, M.A.4
Thébaud, B.5
Bonnet, S.6
Haromy, A.7
Harry, G.8
Moudgil, R.9
McMurtry, M.S.10
Weir, E.K.11
Archer, S.L.12
-
35
-
-
24744440793
-
Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction
-
Hong Z, Smith AJ, Archer SL, Wu XC, Nelson DP, Peterson D, Johnson G, Weir EK. Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation. 2005;112:1494-1499
-
(2005)
Circulation
, vol.112
, pp. 1494-1499
-
-
Hong, Z.1
Smith, A.J.2
Archer, S.L.3
Wu, X.C.4
Nelson, D.P.5
Peterson, D.6
Johnson, G.7
Weir, E.K.8
|